论文信息 - MCL-135 BRUIN MCL-321, a Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Investigator Choice of BTK Inhibitor in Patients With Previously Treated, BTK Inhibitor Naïve Mantle Cell Lymphoma (Trial in Progress). - 字舞流文

MCL-135 BRUIN MCL-321, a Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Investigator Choice of BTK Inhibitor in Patients With Previously Treated, BTK Inhibitor Naïve Mantle Cell Lymphoma (Trial in Progress).

Michael L. Wang | M. Dreyling | C. Cheah | Yucai Wang | W. Jurczak | S. Gouill | J. Sharman | T. Eyre | N. Shah | R. Ito | M. Gandhi | D. Andorsky | E. Vandenberghe | C. Chay | Yuqin Song | Valerie A Muthig | Amy Stark | Valerie A. Muthig